Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Defense was posted on October 15, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

INFLUENZA VIRUS VAC

Awarded
SPE2DP19P0175Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414
New
International
Реагенти для лабораторії імуногенетичних технологій та біоінженерії – ДК 021:2015 – 33690000-3 - Лікарські засоби різні (КЛІТИННА ЛІНІЯ Nalm-6-Zellen – Код ДК 021:2015 – 33696500-0 - Лабораторні реактиви (НК 024:2023/НК 031:2024 – 30670 - Лінія клітинної
Solicitation # UA-2026-11-06-013516-a
The National Children's Specialized Hospital Okhmatdyt of the Ministry of Health of Ukraine is soliciting bids for the procurement of laboratory reagents, specifically the Nalm-6 cell line, for the Laboratory of Immunogenetic Technologies and Bioengineering. This solicitation, identified by number UA-2026-11-06-013516-a, is categorized under various medical and laboratory reagent codes. The performance of the contract and delivery of goods will take place in Kyiv, Ukraine. Interested parties must submit their responses by the deadline of November 22, 2026. A critical compliance requirement for this contract is that the goods provided cannot originate from the Russian Federation, the Republic of Belarus, or the Islamic Republic of Iran. Primary contact for this procurement is Maryna Yakymchuk.
Державне некомерційне підприємство «Національна дитяча спеціалізована лікарня «Охматдит» МОЗ України»

POSTED

3 days ago

DEADLINE

in 13 days
NAICS: 325414
New
DIBBS
MEDICAL PHARMACY EMERGENCY NON NSN ORDER
Solicitation # SPE2DP-26-R-0004
Solicitation SPE2DP-26-R-0004 is a Request for Proposal issued on November 4, 2026, by the Department of Defense Medical Supply Chain Pharmacy FSA for the procurement of egg-free Influenza Virus Vaccine, 2027-2028 Formula for adults aged 18 and older. The government intends to award a Firm Fixed Price, Indefinite Delivery, Indefinite Quantity contract to the responsible offeror determined to be most advantageous based on price and non-price factors. Proposals must be submitted electronically via the DIBBS system by December 3, 2026. Award criteria include the proposed unit and total price, agreement to all solicitation terms without exception, and, for large businesses, the submission of a Small Business Subcontracting Plan. The contract mandates strict quality and cold chain management standards, requiring vaccines to be maintained between 2 to 8 degrees Celsius during transportation for up to 72 hours with no acceptable excursions. Products must be delivered to DLA Distribution Susquehanna in New Cumberland, Pennsylvania, and must have an expiration date no later than 18 months after the date of issue from the manufacturer's cold storage. Manufacturers must be FDA current Good Manufacturing Practice acceptable. Packaging and marking must adhere to Medical Marking Standard No. 1D and MIL-STD-129 for perishables. Invoicing and payment will be processed electronically through the Wide Area Workflow system.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

5 days ago

DEADLINE

in 24 days

AI Contract Overview

Show more

Contract SPE2DP19P0175 was awarded by the Defense Logistics Agency under the Department of Defense to Sequirus USA Inc for the procurement of Influenza Virus Vaccines and associated Federal Excise Tax. The award was posted on October 15, 2026, and originally included line items for the vaccine and tax with an initial total contract value of 121.90 dollars. However, Modification P00001 issued by DLA Troop Support resulted in the total cancellation of the order in accordance with FAR 13.302-4(b). This modification cancelled CLINs 0001 and 0002, effectively reducing the total contract amount to 0.00 dollars with no further cost or liability to either the Government or Sequirus USA Inc.

General Info

DLA awarded Sequirus USA Inc vaccine contract SPE2DP19P0175, which was subsequently fully cancelled.

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Documents

1
PDF, High priority: read this firstmodification
High

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP19P0175 posted on DIBBS. Awardee: SEQIRUS USA INC (CAGE 530P3) Total Contract Price: See Award Doc Award Date: 10-15-2026 Line items: - INFLUENZA VIRUS VAC (NSN/Part 6505016751398) - FEDERAL EXCISE TAX (NSN/Part 0001S00000015)

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS